Dive Into Other Topics

Sep 22, 2023

FDA approved GSK's momelotinib, marketed under name Ojjaara, for management of myelofibrosis in adult patients suffering from anemia.

Sep 20, 2023

Sleep Aids Market: Examining Cutting-Edge Technologies and Scientific Breakthroughs Sleep can be burdensome when it disrupts daily routines, requires a significant time commitment, and is marred by sleep disorders or disturbances that affect overall well-being. In today's fast-paced world, where stress, anxiety,...

Sep 18, 2023

Huntington’s disease is an incurable, rare genetic, progressive neurodegenerative disorder. According to the National Organization for Rare Disorders (NORD), about 30,000 people in the United States have Huntington’s disease, and another 200,000 are at risk of developing the condition. As per DelveInsight analy...

Sep 15, 2023

The dynamics of the myelodysplastic syndrome treatment market are anticipated to change in the coming years owing to the emerging therapies.

Sep 13, 2023

Biosurgery products demand is rising, fueled by the need for innovative surgical solutions and also propelling the market growth.

Sep 06, 2023

Chronic pain is an unwelcome companion in the journey of life and can significantly impact the quality of life. Being in pain serves as a protective mechanism that warns us when something is wrong with the concerned body part, and is a natural component of the human experience. But for millions of people around the...

Sep 04, 2023

As per Delveinsight, the Fabry disease treatment market is likely boost enormous contribution from conventional enzyme replacement therapies.

Aug 30, 2023

Light Therapy is transforming the healthcare market, addressing conditions from mood disorders to skin. Benefits and companies in the market

Aug 23, 2023

Contact lenses have emerged as a groundbreaking innovation within the realm of vision correction, fundamentally reshaping how individuals perceive the world. Serving as an alternative to conventional eyeglasses, contact lenses hold significant value by not only improving visual clarity, but also delivering a natura...

Aug 21, 2023

On August 04, 2023, the FDA has approved Biogen and Sage Therapeutics' Zuranolone as the first tablet for postpartum depression treatment.